Compartir
Título
Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis
Autor(es)
Palabras clave
Anti-NMDA receptor encephalitis
Ovarian teratoma removal
Plasmapheresis
Survival
Young woman
Clasificación UNESCO
3201.08 Ginecología
3201.01 Oncología
Fecha de publicación
2018
Editor
Lippincott Williams and Wilkins
Citación
Ferreira, M. G., Alcalde, V. L., Sánchez, M. H. G., Hernández, L. H., & Doyague Sánchez, M. J. (2018). Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis: A case report. Medicine, 97(31), 11325. https://doi.org/10.1097/MD.0000000000011325
Resumen
[EN]Rationale: This report describes a Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis. Patient Concerns: We present a 31-year-old Caucasian nulliparous patient who was admitted as an emergency with general illness status accompanied by holocranial cephalalgia and fever. Diagnoses: The previous symptoms were followed by disorientation, persecutory delusion, incoherent language, and tonic-clonic seizure. Interventions: The patient was admitted in the intensive care unit (ICU) with Glasgow score 7. Outcomes: Most of complementary exams (brain CT, brain MRI, blood analysis, PCR for virus on CSF) were normal except CSF leucocytosis and hyperproteinorrhachia. An abdominopelvic ultrasound revealed a 5-cm solid-cystic tumor in the left adnexal region, suggestive of teratoma. At that stage, the possibility of autoimmune encephalitis was considered, and confirmed later. Lessons: This disease can only be successfully treated with fast surgical intervention and an early implementation of immunosuppressive therapies. The optimal timing of initiation and duration of therapeutic plasma exchange necessary to achieve good outcomes in patients with NMDAR remains unknown. This case report intends to increase awareness about the importance of early surgical treatment and early implementation of this potentially life-saving therapy and of continuing the treatment until complete remission of symptoms.
URI
ISSN
0025-7974
DOI
10.1097/MD.0000000000011325
Versión del editor
Aparece en las colecciones
Ficheros en el ítem
Tamaño:
912.5Kb
Formato:
Adobe PDF














